We bring expertise in the preclinical study of orthopaedic bone repair, dermal wound repair, dental tissue regeneration, vascular repair and other general surgical indications to address unmet clinical needs.
CY Preclinical Consulting leverages a track record of success and years of industry experience in developing combination biologic/device products that are on the market enhancing healing for patients.
We bring scientific expertise on the biology of amniotic tissue and its application for wound and other tissue repair indications.
Therapeutic Experience
- Dermal Wound Healing
- Chronic and Acute Wounds
- Orthopaedics
- Extremity fusions, Fracture, Spine fusions
- Sports Medicine
- Rotator Cuff repair
- Dental Tissue Regeneration
- Whole tooth regeneration
- Vascular Repair
- Arteriovenous fistula, Arteriovenous grafting
Commercial Product Experience
Dr. Young led the preclinical development for both biologic/device combination and amniotic tissue products for tissue repair and regeneration that are available commercially today.
- AUGMENT® Bone Graft, AUGMENT® Injectable
- Recombinant Human Platelet-Derived Growth Factor-BB Combined with Beta-Tricalcium Phosphate Device Materials for Foot/Ankle Arthrodesis
- DERMAGRAFT®
- Human neonatal dermal fibroblast cells combined with a biodegradable polyester mesh scaffold for treatment of Diabetic Foot Ulcers
- Human amniotic tissue allograft products
- Amniotic tissue products for chronic/acute wound and surgical tissue repair
CY Preclinical Consulting 